COMMUNIQUÉS West-GlobeNewswire

Veritas Pharma Completes Share Purchase Agreement of Sechelt Organic Marijuana Corp.

23/02/2018 - 10:53

VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that it has completed the Share Purchase [...]

Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ

23/02/2018 - 10:07

Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ Paris - February 23, 2018 - Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, [...]

Sanofi : Sanofi annonce l'expiration de la période d'attente prévue par la loi Hart-Scott-Rodino pour l'acquisition de Bioverativ

23/02/2018 - 10:07

Sanofi annonce l'expiration de la période d'attente prévue par la loi Hart-Scott-Rodino pour l'acquisition de Bioverativ Paris - Le 23 février 2018 - Sanofi annonce aujourd'hui la fin de la période d'attente prévue par [...]

Medtech specialist Acarix AB names Christian Lindholm as Interim CEO

23/02/2018 - 10:01

Press release Malmö, February 23, 2018 Medtech specialist Acarix AB names Christian Lindholm as Interim CEO Acarix AB (publ) ("Acarix"), developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment [...]

Montebello to distribute Biohit products in Norway

23/02/2018 - 09:00

Biohit Oyj Press release, February 23rd, 2018 at 10:00 a.m. local time (EET) Biohit Oyj and Montebello Diagnostics AS have signed an agreement for the distribution of Biohit diagnostic products in Norway. The contract [...]

Aino Health AB (publ): publishes Year-end Report October - December 2017

23/02/2018 - 08:31

Aino Health AB (publ) has published its Year-end Report for the period, 1 October - 31 December 2017 today. It is available on the Aino Health website, see also attached pdf-document. Significant events - Business [...]

Notice for the Annual General Meeting of Novo Nordisk A/S

23/02/2018 - 08:02

Bagsværd, Denmark, 23 February 2018 - The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 22 March 2018 at 2.00 pm (CET) at Royal Arena, entrance G, Hannemanns Allé 20, 2300 Copenhagen S, Denmark. [...]

FDA Accepts Shire's BLA and Grants Priority Review for Lanadelumab for the Prevention of Attacks in HAE Patients

23/02/2018 - 08:00

FDA Accepts Shire's Biologics License Application (BLA) and Grants Priority Review for Lanadelumab for the Prevention of Attacks in Hereditary Angioedema (HAE) Patients - Lanadelumab, the first long-acting [...]

Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract

23/02/2018 - 07:16

Basel, Switzerland, February 23, 2018 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has commenced enrollment in the first of its two planned clinical phase 3 registration studies of the antibiotic [...]

Addex Publishes Extraordinary General Meeting Invitation

23/02/2018 - 07:01

Geneva, Switzerland, 23 February 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that it has published the Invitation to its [...]

Dova Pharmaceuticals, Inc. Announces Pricing of Offering of Common Stock

23/02/2018 - 01:30

DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is [...]

Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018

22/02/2018 - 23:59

MEDFORD, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for [...]

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress

22/02/2018 - 23:17

SAN DIEGO, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering [...]

Helix BioPharma Corp. Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities

22/02/2018 - 23:00

RICHMOND HILL, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FRANKFURT: HBP ) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates [...]

Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results

22/02/2018 - 22:46

Reaffirms full year 2018 forecast and 2020 goals Revises 1Q 2018 forecast GAITHERSBURG, Md., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) reported financial results for the quarter and [...]

Harvard Bioscience Schedules Fourth Quarter 2017 Conference Call for March 1 at 4:30 PM ET

22/02/2018 - 22:45

HOLLISTON, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]

Arbutus Settles Litigation, Terminating Acuitas’ Rights to LNP Technology

22/02/2018 - 22:35

Acuitas has No Further Rights to Use or Sublicense Arbutus LNP Technology Arbutus Consolidates LNP Patent Estate Enabling RNAi, mRNA, and Gene-editing Therapeutics VANCOUVER, B.C. and WARMINSTER, Pa., Feb. 22, 2018 ( [...]

Emisphere Development Update

22/02/2018 - 22:18

ROSELAND, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced today the successful completion of the first phase 3a trial, PIONEER 1, with oral semaglutide, a once-daily oral formulation of the long-acting [...]

SteraMist™ Makes a Big Difference in Efforts to Fight the Flu in a Delaware Hospital

22/02/2018 - 22:16

BEVERLY HILLS, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ) is a global company that specializes in plasma science based disinfection/decontamination using its [...]